Last updated 2026-07-20
Portfolio
4
in our dataset
Rounds participated
4
Rounds led
0
Rounds' value
$36.0M
total disclosed, rounds participated
Stages
C Round, G Round, A Round, Seed, F Round, E Round, B Round, D Round
About
Founded by Leon Recanati in 2003, the GlenRock Group is a private equity investment firm based in Herzliya, Israel. The firm leverages a unique combination of private equity, multidisciplinary in-house expertise, and access to quality deal flow. GlenRock takes an active and long-term role in the development and growth of its portfolio companies, focusing on hand-picked solutions with viable business models that address real needs in strong growth-potential markets. Their investment strategy encompasses life sciences, advanced technology, auto-tech, cybersecurity, and other advanced technologies.
Portfolio · 4
Investment activity
14 portfolio exits on record.
Portfolio by sector
Health Tech & Life Sciences12
Industrial Technologies5
Business Software4
Cyber Security3
Aerospace, Defense & HLS1
Energy Tech1
Media & Entertainment Technologies1
Automotive & Mobility Technologies1
Q&A
- What are GlenRock Group's most recent exits?
- GlenRock Group has two recent exits: Capitalise was acquired by Kraken in August 2025, and Model9 was acquired by BMC Software in April 2023.
- Which sectors does GlenRock Group primarily invest in?
- GlenRock Group shows a strong concentration in Health Tech & Life Sciences, with 12 portfolio companies, and Industrial Technologies, with 5 portfolio companies.
- Can you name some of GlenRock Group's portfolio companies in the Cyber Security sector?
- GlenRock Group's portfolio includes CyberX, which was acquired by Microsoft in June 2020, and Cylus, a railway cybersecurity solutions provider.
- What is GlenRock Group's investment focus according to their thesis?
- GlenRock Group is a single-family office that focuses on Life Sciences, Advanced Technology, and Private Equity, taking an active and long-term role in their portfolio companies.
- Which public exits has GlenRock Group had in recent years?
- GlenRock Group has seen several public exits, including Teads, which went public on NASDAQ in July 2021 with a valuation of $1.25 billion, and Idomoo, which went public on TASE in June 2021 with a valuation of $105.83 million.
- Who are the key personnel at GlenRock Group?
- The key personnel at GlenRock Group include Leon Recanati, the Founder & CEO, and Asaf Iram, a Managing Partner.
- Has GlenRock Group had any notable exits in the Health Tech & Life Sciences sector?
- Yes, Cardiovalve was acquired by Venus Medtech for $150 million in March 2022, and LifeBond was acquired by Bard Medical for $60 million in January 2020.
- What is the typical investment stage for GlenRock Group?
- GlenRock Group invests across various stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | grg.co.il/ |
|---|
Identifiers & details
| Founded | 2003 |
|---|
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | grg.co.il |
|---|